Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.

Bitcoin giant Strategy kept its spot in the Nasdaq 100 on Friday, holding its year-long run inside the index while debate ...

Walmart transferred to the Nasdaq too late to be eligible for the Nasdaq-100's annual reconstitution. Six companies will join the Nasdaq-100 later this month - but not Walmart, which switched its ...

Lululemon Athletica (LULU) to exit the Nasdaq 100 as part of the gauge's annual shakeup, with Seagate (STX) and five others ...

Bitcoin hoarding giant Strategy clung to its place in the Nasdaq 100 on Friday, continuing its year-long stint in the ...

First Patient Expected to be Dosed Next Week with Intranasal Foralumab PET Scan Shows Presence of Untreated Neuroinflammation ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Shares of AC Immune rose by double-digits on news that the company, encouraged by new data, now intends to ask drug ...

Biogen (BIIB) stock slips as HSBC downgrades to a Sell equivalent rating as part of an analysis that included an upgrade on ...

Health Canada has approved the first drug designed to treat postpartum depression. Zuranolone, sold under the brand name ...

HSBC analyst Rajesh Kumar downgraded Biogen Inc. (NASDAQ: BIIB) from Hold to Reduce and slashed the price target from $144 to ...

Health Canada has approved zuranolone, sold under the brand name Zurzuvae, as the first oral treatment for moderate to severe ...